Better Coronavirus Stock: Regeneron or Eli Lilly?
There are a lot of unknowns surrounding the coronavirus pandemic, but one thing is clear. There's a lot of demand for potential COVID-19 treatments from Regeneron (NASDAQ: REGN) and Eli Lilly (NYSE: LLY) if they can be proven safe and effective in clinical trials that are taking place right now.
It might not feel like it, but the coronavirus pandemic will eventually end along with soaring demand for treatments for infected patients. That means investors want shares of companies positioned to thrive even if things don't work out for their COVID-19 treatment candidates, and these two fit the bill. Let's stack them side by side to see which is the better stock to buy at the moment.
Image source: Getty Images.
Source Fool.com
